Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that's 25 years of bringing you fearless, independent reporting. Since our very first broadcast in 1996, Democracy Now! has refused to take government or corporate funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. If everyone who tunes into Democracy Now! signed up for a monthly donation of just $10, we could cover our operating costs for the entire year. Please do your part today. Right now, a generous donor will even DOUBLE your first monthly gift, which means it’ll go twice as far! This is a challenging time for us all, but if you're able to start a new monthly donation, please don’t delay. We’re counting on your support. Thank you and remember, wearing a mask is an act of love.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


COVAX Cuts 2021 Vaccine Forecast; Australia Joins Call for Waiver on Vaccine Patents

HeadlineSep 09, 2021

On Wednesday, U.N. officials said the COVAX initiative to bring vaccines to poor and middle-income nations was falling further behind its initial target of 2 billion doses this year. COVAX is now projecting about 1.4 billion doses delivered through December.

Meanwhile, vaccine equity activists are cheering moves by Australia’s government to support a suspension of intellectual property rights for COVID vaccines. Australia’s trade minister said this week the government now supports calls for a temporary waiver of vaccine patent rights at the World Trade Organization. Such a move would require consensus at the WTO, where Germany and the United Kingdom are blocking the move to allow generic versions of vaccines produced by companies including Pfizer and Moderna.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation